Navigation Links
A Worm Turns: Banking on Blood From a Little Lugworm

An inconspicuous lugworm has aroused scientists' curiosity, as a potential provider of artificial blood, indeed considered a breakthrough in the medical field.// The red liquid that courses through our veins, very much our lifeline has always been in great demand. Often, there is a huge scamper for blood during complex surgeries to save the life of the patient.

Nature seems to have many secrets in store, and a little worm which is popularly called the lug worm, and commonly used by fish folk as bait, stands a good chance of elevating its position to that of a life saver. This idea first struck the English and French scientists, who knew of the presence of pure blood in the lug worms. Further, lug worms use hemoglobin to execute blood circulation in the body and the fact that it lives in the earth below lends an added advantage of assisting in a better utilization of oxygen molecules. Importantly, synthetic blood has the capacity to carry 40 times more oxygen than normal blood.

This finding will help augment times of acute shortage of blood, while also assisting in keeping the transplant organs in ship shape during surgeries. Professor Peter Olive, a marine biologist at Newcastle University, UK, said: “It (the lugworm) lives in the mud where it has to get oxygen and so its hemoglobin has a very particular structure that makes it very effective at binding oxygen. It’s nearly an ideal structure for carrying oxygen.”

Teaming up with the French scientists, they extracted the protein, which was purified to form an artificial blood solution. This water-based solution can be given to any receiver, irrespective of the blood group.

Professor Olive added: “Nature has given us a solution to one of the great quests in the world of science and medicine. Blood transfusion is by nature a difficult process because blood is a complex material. The end product will be a solution that can be used to carry high levels of oxygen into the body. Ef fectively it is a blood substitute. It can be used in many different medical processes. From treatment of traumatic injuries like car accidents to cancer and stroke patients.”

'"/>




Related medicine news :

1. A Novel System For Clinical Banking Of Umbilical Cord Blood
2. Doctor Dissuades Mothers from Umbilical Cord Banking
3. Banking (T)issues : cloning issue surfaces
4. Stem Cell Banking Evokes Mixed Response
5. Umbilical Cord Blood Banking of Negligible Value: Experts
6. Recommendations for Treatment of Blood Pressue
7. Blood Cells Capable of Regenerating Liver
8. Blood clots likely in long travel
9. Hemochromatosis Patients Blood is Safe
10. Blood transfusions beneficial after heart attacks
11. Blood Pressure Drug may slow wasting in burn victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: